{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:22:34Z","timestamp":1781227354341,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00380-019-01475-1","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T17:02:37Z","timestamp":1564074157000},"page":"239-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Association between left atrial reverse remodeling and maintenance of sinus rhythm after catheter ablation of persistent atrial fibrillation"],"prefix":"10.1007","volume":"35","author":[{"given":"Yoshihiko","family":"Kagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6876-7695","authenticated-orcid":false,"given":"Eitaro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"1475_CR1","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","volume":"48","author":"C Pappone","year":"2006","unstructured":"Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V (2006) A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 48:2340\u20132347","journal-title":"J Am Coll Cardiol"},{"key":"1475_CR2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/j.1540-8167.2007.00930.x","volume":"18","author":"C Schmitt","year":"2007","unstructured":"Schmitt C, Estner H, Hecher B, Luik A, Kolb C, Karch M, Ndrepepa G, Zrenner B, Hessling G, Deisenhofer I (2007) Radiofrequency ablation of complex fractionated atrial electrograms (CFAE): preferential sites of acute termination and regularization in paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 18:1039\u20131046","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1475_CR3","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","volume":"372","author":"A Verma","year":"2015","unstructured":"Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P, Investigators STARAFII (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372:1812\u20131822","journal-title":"N Engl J Med"},{"key":"1475_CR4","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1161\/CIRCULATIONAHA.104.523928","volume":"112","author":"P Reant","year":"2005","unstructured":"Reant P, Lafitte S, Jais P, Serri K, Weerasooriya R, Hocini M, Pillois X, Clementy J, Haissaguerre M, Roudaut R (2005) Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation. Circulation 112:2896\u20132903","journal-title":"Circulation"},{"key":"1475_CR5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jjcc.2009.12.007","volume":"55","author":"M Senga","year":"2010","unstructured":"Senga M, Fujii E, Sugiura S, Yamazato S, Sugiura E, Nakamura M, Miyahara M, Ito M (2010) Efficacy of linear block at the left atrial roof in atrial fibrillation. J Cardiol 55:322\u2013327","journal-title":"J Cardiol"},{"key":"1475_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10840-011-9633-6","volume":"34","author":"S Sugiura","year":"2012","unstructured":"Sugiura S, Fujii E, Senga M, Sugiura E, Nakamura M, Ito M (2012) Clinical features of patients with left atrial thrombus undergoing anticoagulant therapy. J Interv Card Electrophysiol 34:59\u201363","journal-title":"J Interv Card Electrophysiol"},{"key":"1475_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.hrthm.2008.10.038","volume":"6","author":"JH Li","year":"2009","unstructured":"Li JH, Haim M, Movassaghi B, Mendel JB, Chaudhry GM, Haffajee CI, Orlov MV (2009) Segmentation and registration of three-dimensional rotational angiogram on live fluoroscopy to guide atrial fibrillation ablation: a new online imaging tool. Heart Rhythm 6:231\u2013237","journal-title":"Heart Rhythm"},{"key":"1475_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/europace\/eur003","volume":"13","author":"G N\u00f6lker","year":"2011","unstructured":"N\u00f6lker G, Gutleben KJ, Asbach S, Vogt J, Heintze J, Brachmann J, Horstkotte D, Sinha AM (2011) Intracardiac echocardiography for registration of rotational angiography-based left atrial reconstructions: a novel approach integrating two intraprocedural three-dimensional imaging techniques in atrial fibrillation ablation. Europace 13:492\u2013498","journal-title":"Europace"},{"key":"1475_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00380-018-1180-y","volume":"33","author":"S Fujita","year":"2018","unstructured":"Fujita S, Fujii E, Kagawa Y, Inoue K, Yamada T, Ito M (2018) The seamless integration of three-dimensional rotational angiography images into electroanatomical mapping systems to guide catheter ablation of atrial fibrillation. Heart Vessels 33:1373\u20131380","journal-title":"Heart Vessels"},{"key":"1475_CR10","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1161\/01.CIR.0000144459.37455.EE","volume":"110","author":"F Ouyang","year":"2004","unstructured":"Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M, Chun J, Falk P, Khanedani A, Antz M, Kuck KH (2004) Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 110:2090\u20132096","journal-title":"Circulation"},{"key":"1475_CR11","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.jacc.2003.12.054","volume":"43","author":"K Nademanee","year":"2004","unstructured":"Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43:2044\u20132053","journal-title":"J Am Coll Cardiol"},{"key":"1475_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.joa.2017.07.003","volume":"33","author":"Y Kagawa","year":"2017","unstructured":"Kagawa Y, Fujii E, Fujita S, Yamada N, Ito M (2017) Three cases of vasospastic angina following catheter ablation of atrial fibrillation. J Arrhythm. 33:511\u2013513","journal-title":"J Arrhythm."},{"key":"1475_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.amjcard.2005.11.043","volume":"97","author":"LF Tops","year":"2006","unstructured":"Tops LF, Bax JJ, Zeppenfeld K, Jongbloed MR, van der Wall EE, Schalij MJ (2006) Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size. Am J Cardiol 97:1220\u20131222","journal-title":"Am J Cardiol"},{"key":"1475_CR14","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.104.484766","volume":"112","author":"WP Beukema","year":"2005","unstructured":"Beukema WP, Elvan A, Sie HT, Misier AR, Wellens HJ (2005) Successful radiofrequency ablation in patients with previous atrial fibrillation results in a significant decrease in left atrial size. Circulation 112:2089\u20132095","journal-title":"Circulation"},{"key":"1475_CR15","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/eurheartj\/ehm027","volume":"28","author":"A Berruezo","year":"2007","unstructured":"Berruezo A, Tamborero D, Mont L, Benito B, Tolosana JM, Sitges M, Vidal B, Arriagada G, M\u00e9ndez F, Matiello M, Molina I, Brugada J (2007) Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 28:836\u2013841","journal-title":"Eur Heart J"},{"key":"1475_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0735-1097(02)01939-3","volume":"40","author":"H Oral","year":"2002","unstructured":"Oral H, Knight BP, Ozaydin M, Tada H, Chugh A, Hassan S, Scharf C, Lai SW, Greenstein R, Pelosi F Jr, Strickberger SA, Morady F (2002) Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 40:100\u2013104","journal-title":"J Am Coll Cardiol"},{"key":"1475_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.hrthm.2004.07.020","volume":"1","author":"K Lemola","year":"2004","unstructured":"Lemola K, Sneider M, Desjardins B, Case I, Chugh A, Good E, Han J, Tamirisa K, Tsemo A, Reich S, Tschopp D, Igic P, Elmouchi D, Bogun F, Pelosi F Jr, Kazerooni E, Morady F, Oral H (2004) Effects of left atrial ablation of atrial fibrillation on size of the left atrium and pulmonary veins. Heart Rhythm 1:576\u2013581","journal-title":"Heart Rhythm"},{"key":"1475_CR18","first-page":"163","volume":"13","author":"JH Wu","year":"2016","unstructured":"Wu JH, Li HK, Couri DM, Araoz PA, Lee YH, Ma CS, Packer DL, Cha YM (2016) Reversal of pulmonary vein remodeling after catheter ablation of atrial fibrillation. J Geriatr Cardiol 13:163\u2013168","journal-title":"J Geriatr Cardiol"},{"key":"1475_CR19","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00380-017-1008-1","volume":"32","author":"Y Fujimoto","year":"2017","unstructured":"Fujimoto Y, Yodogawa K, Takahashi K, Tsuboi I, Hayashi H, Uetake S, Iwasaki YK, Hayashi M, Miyauchi Y, Shimizu W (2017) Noninvasive evaluation of reverse atrial remodeling after catheter ablation of atrial fibrillation by P wave dispersion. Heart Vessels 32:1375\u20131381","journal-title":"Heart Vessels"},{"key":"1475_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1540-8159.2010.02693.x","volume":"33","author":"SS Parikh","year":"2010","unstructured":"Parikh SS, Jons C, McNitt S, Daubert JP, Schwarz KQ, Hall B (2010) Predictive capability of left atrial size measured by CT, TEE, and TTE for recurrence of atrial fibrillation following radiofrequency catheter ablation. Pacing Clin Electrophysiol 33:532\u2013540","journal-title":"Pacing Clin Electrophysiol"},{"key":"1475_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijcard.2010.08.034","volume":"153","author":"C Jahnke","year":"2011","unstructured":"Jahnke C, Fischer J, Gerds-Li JH, Gebker R, Manka R, Fleck E, Paetsch I, Kriatselis C (2011) Serial monitoring of reverse left-atrial remodeling after pulmonary vein isolation in patients with atrial fibrillation: a magnetic resonance imaging study. Int J Cardiol 153:42\u201346","journal-title":"Int J Cardiol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-019-01475-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T23:26:49Z","timestamp":1595546809000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-019-01475-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1007\/s00380-019-01475-1","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"18 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Masaaki Ito received honoraria equal to or more than 500,000 yen from Daiichi Sankyo Company Limited, Bayer Holding Ltd., and Mitsubishi Tanabe Pharma Corporation in 2016, and from Daiichi Sankyo Company Limited, Bayer Holding Ltd., and Takeda Pharmaceutical Company Limited in 2017. The Department of Cardiology and Nephrology, Mie University Graduate School of Medicine was supported in part by unrestricted research grants of equal to or more than 1,000,000 yen from MSD K.K., Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Otsuka Pharma Inc., Daiichi Sankyo Company Limited, and Shionogi & Co., Ltd. in 2016, from Bristol-Myers Squibb K.K., MSD K.K., Shionogi & Co., Ltd., Otsuka Pharma Inc., Takeda Pharmaceutical Company Limited and Daiichi Sankyo Company Limited in 2017, and from Otsuka Pharma Inc. and Daiichi Sankyo Company Limited in 2018. Grants of 1,000,000 yen or more annually for research work (collaborative study, consignment study, or clinical trial), which the author is substantially authorized to use, were received from Daiichi Sankyo Company Limited in 2017 and 2018. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}